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Nitric oxide drives skin repair: Novel functions of an estab- cal outcome. To this end, our search for novel mediators
lished mediator. Wound healing of the skin represents a highly has to proceed with the intent to develop novel concepts
ordered process of important tissue movements that aims for to improve healing of chronic skin wounds.a rapid closure of the wound site and a subsequent regeneration
In most cases, skin injury results in the extravasationof the injured tissue. The factors ensuring the intercellular
of blood constituents from damaged vessels. Blood coag-communication during repair are only known in part. However,
although protein-type mediators are well-established players in ulation then results from a cascade of events that are
this process, it has become evident that the diffusible, gaseous closely associated to platelet aggregation at the wound
molecule nitric oxide (NO) participates in the orchestration of site. As a result, a clot is generated that covers thewound healing. The role of wound-derived NO that critically
wounded area, plugs the injured vessels, represents ainfluences macrophage, fibroblast, and keratinocyte behaviour
provisional matrix for infiltrating cells, and serves aswithin the intercellular communication network during repair
is subject of this review. Thus, cutaneous wound healing proto- a reservoir of chemotactic mediators, cytokines, and
typically reflects processes that generally occur also in kidney growth factors that initiate and promote early tissue
injury and regeneration.
movements [2–4].
Polymorphonuclear neutrophils (PMN) and mono-
cytes represent the first cells that arrive at the wounded
To overcome tissue damage, the process of cutaneous area. Both leukocytic cell types are attracted from the
wound repair represents a highly ordered process that circulation by a variety of chemotactic factors. Among
is characterized by temporally and spatially overlapping those, the CXC-chemokines and CC-chemokines repre-
phases of tissue movements comprising hemorrhage, in- sent potent attractors for both PMN and monocytes,
flammation, re-epithelialization, granulation tissue for- respectively, within the process of skin repair in mice
mation, and the late remodeling phase of repair. As and humans [5]. Once they arrive at the site of injury,
a result, the integrity of the body’s protective layer is
PMN process extracellular matrix (ECM) components,
maintained, although repair fails to perfectly replace the
decontaminate bacteria, and produce cytokines. Arriv-
original skin tissue. Loss of a functional healing process
ing monocytes differentiate into mononuclear phago-
might lead to severe disabilities. Accordingly, chronic,
cytes at the wound site. Activated macrophages arenon-healing wound conditions represent a situation of
central to wound repair, as they amplify the initial in-major clinical importance. A series of pathological changes
flammatory response by release of a variety of signalingaccompanied with several diseases finally leads to se-
molecules, and, moreover, provide growth factors forverely disturbed wound healing conditions. Among those,
fibroblast and endothelial cell proliferation and contrib-the most prominent chronic wound situations are known
ute to ECM degradation [2–4, 6].as decubitus or pressure ulcers, venous ulcers, and diabetic
After a short lag period of several hours after injury,ulcers [1]. Molecular and cellular biology and the use of
the opening phase of re-epithelialization is marked bydifferent model systems, especially including genetically
the first keratinocytes of the cut edges starting to migrate.engineered animals, have greatly extended our knowl-
Keratinocytes were guided into the wound by fibronectinedge on skin repair. Nevertheless, the most promising
and fibrin bundles in the provisional clot, which arediscoveries of growth factor actions for repair to date
sensed by the cells by expression of highly controlledcould not be successfully translated with respect to clini-
integrin receptor subsets [2]. Migrating keratinocytes do
not differentiate, and the leading edge keratinocytes ex-
press constituents of a very active fibrinolytic machineryKey words: wound repair, cutaneous wound, immune response, injury,
re-epithelialization. such as plasminogen activators and matrix metalloprotei-
nases (MMP) [3]. Keratinocytes at the wound margins 2002 by the International Society of Nephrology
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Fig. 1. Intercellular communication network
in a skin wound three days after injury.
Protein-type growth factors are well estab-
lished to orchestrate cell movements at the
wound site. Abbreviations are: FGF, fibro-
blast growth factor; KGF, keratinocyte growth
factor; PDGF, platelet-derived growth factor;
TGF, transforming growth factor; VEGF, vas-
cular endothelial growth factor.
Fig. 2. Nitric oxide (NO) as a signaling mole-
cule at the wound site. The gaseous molecule
NO serves as a mediator that regulates gene
expression and proliferation in keratinocytes,
and collagen synthesis in fibroblasts. Abbrevi-
ations are: NO, nitric oxide; MCP-1, macro-
phage chemoattractant protein-1; RANTES,
regulated upon activation, normal T-cell ex-
pressed and secreted; VEGF, vascular endo-
thelial growth factor.
start to proliferate one or two days after injury. Re- rophages, fibroblasts, and endothelial cells. Interaction
of these cell types leads to deposition of newly synthe-epithelialization is closely controlled by growth factors,
predominantly by members of the epidermal growth fac- sized connective tissue and ingrowth of new blood ves-
sels. Wound fibroblasts own three main capacities: prolif-tor (EGF)- [3], and fibroblast growth factor (FGF)- [7]
family of growth factors. However, unexpected media- eration, migration and production of ECM. Additionally,
fibroblasts contribute to the “growth factor cocktail”tors such as the cytokine leptin [8] or the small gaseous
molecule nitric oxide (NO) [9], as reviewed below, cru- by secreting important mediators such as keratinocyte
growth factor (KGF), connective tissue growth factorcially contribute to cutaneous re-epithelialization also.
Formation of the granulation tissue starts about three (CTGF), or activin. To make their way into the wound
site, migratory fibroblasts express a series of proteolyticto four days after injury (Figs. 1 and 2) [2–4]. The main
cell types driving the generation of new stroma are mac- enzymes (MMP-1, -2, -3). As repair progresses, the mi-
Frank et al: NO and wound healing884
gratory phenotype is subsequently changed into a profi- including psoriasis, lupus erythematosus, inflammatory
brotic one, and fibroblasts start to deposit collagen, a dermatoses, and hypersensitivity reactions [20].
process that is potently regulated by the action of trans-
forming growth factor-1 (TGF-1). A proportion of
L-ARGININE AND WOUND HEALINGwound fibroblasts specializes into myofibroblasts, which
finally decrease the overall wound size by contracting the Wound healing of the skin is a highly coordinated
granulation tissue. Neovascularization has to accompany process, finally leading to an at least partial reconstruc-
granulation tissue formation, as the newly forming cellu- tion of the injured tissue. The factors mediating the inter-
lar complex must be supplied with oxygen and nutrients. cellular communication during wound repair are known
Outgrowth of endothelial cells from pre-existing vessels in part, but their number is still increasing. Proinflamma-
at the wound margins is triggered by a series of angio- tory cytokines and various peptide growth factors are
genic factors that activate endothelial cell proteases that known to be key players in this process [3]. However,
are crucial for the cells to transmigrate the basement these protein-type factors are not unique in regulating
membrane and infiltrate the wound. Especially vascular
cellular behavior in wound repair, and evidence is emerg-
endothelial growth factor (VEGF), which is expressed in
ing for an important role of small diffusible moleculeslarge amounts by epidermal cells during repair, regulates
in wound repair. One of them is NO, a free radical gas,endothelial cell action at the wound site. Finally, the
which has become one of the most studied molecules inlate phase of granulation arises when wound fibroblasts
biomedical sciences during the past years.undergo apoptosis, and, thus, mark the transition from
It has long been known that the amino acid l-arginine,a cell-rich granulation tissue to a more or less acellular
representing the only substrate for NOS enzymatic activ-scar.
ity, is implicated in wound healing. An initial study from
nearly 25 years ago demonstrated the influence of l-argi-
NITRIC OXIDE AND SKIN nine supplementation on healing of wounds in a rat
In mammals, the synthesis of nitric oxide (NO) is cata- model of incisional repair [22]. Arginine-deficient ani-
lyzed by NO synthase (NOS) that exists in three distinct mals showed an impaired healing, as assessed by mark-
isoforms [10]. NOS catalyzes the oxidation of the amino edly decreased wound breaking strength and collagen
acid l-arginine to finally release citrulline and NO. Mo- deposition, which was thought to be associated with an
lecular cloning has revealed the existence of three differ- l-arginine–induced growth hormone release [22]. A few
ent NOS isoforms: the constitutively expressed neuronal years later, Albina and colleagues determined enzymatic
(nNOS) and endothelial (eNOS) NOS isoforms, and the activities of the oxidative l-arginine deiminase (OAD)
inducible NOS (iNOS) isoenzyme, respectively [10, 11]. and arginase in wound fluids isolated from implanted
All three NOS isoenzymes are homodimeric proteins sponges in the rat [23]. OAD catalyzes the reaction of
that depend on nicotinamide adenine dinucleotide phos- l-arginine into citrulline and nitrogen intermediates and,
phate (NADPH), reduced flavins, heme-bound iron, and thus, clearly resembles the more recently identified NOS.
6(R) 5,6,7,8-tetrahydrobiopterin as essential cofactors. In this model of repair, wound fluids were characterized
The constitutively expressed NOS isoforms are activated by low arginine levels, which directly implicate a con-
by increasing Ca2 levels via calmodulin. It is well estab- sumption of l-arginine at the wound site. Moreover,
lished that all three NOS isoforms are expressed in skin
citrulline and nitrite, products of the OAD or NOS activ-
tissue. Expression of nNOS has been observed in kera-
ity, respectively, peaked within the early, inflammatorytinocytes and melanocytes [12, 13], expression of eNOS
phase of healing [23, 24]. l-Arginine levels remainedcould be detected in keratinocytes of the basal epidermal
low, as the amino acid is subject to the catalytic activitylayer, dermal fibroblasts, endothelial capillaries and ec-
of arginase later in repair, releasing measurable amountscrine glands [14, 15], whereas iNOS can be induced in
of ornithine into the wound fluid [23]. However, thekeratinocytes [16, 17], fibroblasts [15], Langerhans [18]
potency of l-arginine to improve wound healing mustand endothelial cells [19]. It is now reasonable to assume
be tightly linked to both the NOS and arginase enzymethat NO participates in the regulation of skin homeo-
systems, as the loss of a functional iNOS gene in iNOS-static functions such as circulation, UVB-mediated mela-
deficient mice abrogates the beneficial effects of l-argi-nogenesis, sunburn erythema, and the maintenance of
nine in wound healing [25]. Consistently, the beneficialthe protective barrier against microorgansims [20]. In
effects of l-arginine observed in animal models also wereline, NO restricts pathogen growth after cutaneous infec-
confirmed in humans. Clinical studies demonstrated antion [21]. In general, the presence of iNOS is associated
enhanced wound healing in l-arginine supplemented pa-with pathological conditions, a situation that also is true
tients that was characterized by a markedly increasedof skin tissue. Accordingly, the expression of iNOS has
been described for inflammatory diseases of the skin, wound collagen deposition [26, 27].
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SPECIFIC ROLES OF iNOS AND eNOS To date, information dealing with an in vivo function
of eNOS-derived NO in skin repair is clearly restricted.ISOENZYMES IN WOUND HEALING
However, eNOS also contributes to wound-related NOAlthough an important role for NO in skin repair has
production, as eNOS knockout mice were characterizedbeen well defined within the last decade, the specific
by an even more pronounced delay in wound closureroles of distinct NOS isoenzymes for wound-derived NO
compared to iNOS-deficient animals as assessed by theproduction could only be addressed when NOS-deficient
same model of full-thickness skin wounding [31]. In par-knockout mice or NOS isoenzyme-specific inhibitors be-
allel to the delayed wound closure, the tensile strength ofcame available. Nevertheless, utilization of wound heal-
the regenerating tissue was markedly reduced in eNOSing models in either normal or transgenic animals, or
knockout mice [31], indicating an important role forof specific iNOS inhibitors, respectively, predominantly
eNOS-derived NO for ECM production (see the section,revealed the first insights in the regulation and possible
Nitric oxide and wound fibroblasts). The study suggestsroles of the iNOS isoform during repair.
defects in angiogenic processes during repair that areData obtained from iNOS-deficient mice clearly indi-
associated with the absence of eNOS. Thus, in vitro andcated an important role for iNOS-derived NO in wound
in vivo experiments implicated that eNOS contributeshealing. The average time of wound closure was signifi-
to granulation tissue formation by triggering endothelialcantly delayed in the knockout animals in a model of full-
migration, proliferation and differentiation and, thus, itthickness excisional wounding. The disparity between
participates in capillary ingrowth into the wound sitenormal and knockout mice upon injury became greater
during repair [31].with time finally resulting in an average delay of 31%
in iNOS-deficient animals [28]. Inhibition of iNOS enzy-
matic activity during repair in wild-type mice using N6- NITRIC OXIDE AND WOUND MACROPHAGES
(iminoethyl)-l-lysine (L-NIL) resulted in a similar delay
Interestingly, the observed wound-related OAD/NOSin complete wound closure as compared to iNOS kock-
activity was exclusively connected to viable macrophagesout mice. More important, functional evidence for iNOS-
at the wound site in early studies [23]. More recent dataderived NO in skin repair was evidenced by an adenovi-
confirmed the wound macrophage as a prominent sourceral-mediated expression of a human iNOS cDNA at
of iNOS expression in the early inflammatory phase ofwound sites in iNOS-deficient mice, which led to an
repair [30]. This observation might relate to findings thataccelerated wound closure that was comparable to heal-
define sites of inflammation with prominent macrophageing in control animals [28]. These data were consistent
infiltration as uniquely deficient in l-arginine. Consis-with the induction of iNOS expression upon cutaneous
tently, the l-arginine metabolism via NOS and arginaseinjury in a murine model of normal healing [29]. iNOS
appears to be closely counter-regulated in macrophages.levels remained elevated during the inflammatory phase
Factors increasing macrophage iNOS activity, such as in-of repair with infiltrating PMN and macrophages as one
terferon- (IFN-) or bacterial lipopolysaccharide (LPS),major source of iNOS expression [29, 30]. Interestingly,
decrease arginase activity in the cells, whereas trans-iNOS expression was not restricted to immune cells, as
forming growth factor-1 (TGF-1)–mediated iNOS in-proliferating keratinocytes of the wound margins, and
hibition resulted in increasing ornithine levels [32]. Thisto a smaller extent also wound fibroblasts expressed
hypothesis is supported by yet unpublished observationsiNOS [29]. In line with data obtained from iNOS knock-
from our laboratory, where chronic, non-healing woundout mice [28], a glucocorticoid-mediated delay in wound
situations in diabetic db/db mice were characterized byclosure in wild-type animals was associated with a mark-
tremendous numbers of macrophages at the wound siteedly reduced presence of iNOS at the wound site [29].
that were associated with a lack of iNOS expression inFor the first time, application of an iNOS inhibitory
the presence of an overshooting expression of arginasesubstance, L-NIL, during wound healing revealed an im-
portant role of iNOS in regulation of epithelial tissue (S. Frank, H. Ka¨mpfer, unpublished observations).
movements [9]. L-NIL is now established as a partially
selective inhibitor of iNOS, with a 50-fold selectivity for
NITRIC OXIDE AND WOUND FIBROBLASTSiNOS versus eNOS, or 20-fold selectivity versus nNOS,
In vitro studies have convincingly demonstrated thatrespectively [10]. Compared with control mice, L-NIL-
human skin-derived fibroblasts spontaneously possesstreated animals were characterized by a severely impair-
the capacity to produce NO that is either linked to theed re-epithelialization process, as the hyperproliferative
Ca2-dependent eNOS isoenzyme and—after stimula-epithelia at the wound edges appeared to be delayed and
tion of the cells with IFN- and LPS—to the iNOS iso-characterized by an atrophied morphology. Moreover,
form [15]. Independent from the cellular source it derivesproliferating keratinocyte cell numbers were strongly
from during repair, NO predominantly regulates colla-reduced during re-epithelialization after inhibition of
iNOS during repair [9]. gen synthesis in wound fibroblasts, the cell type that
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represents a central player in the formation of new increased proliferation at low and cytostasis associated
with differentiation at high NO concentrations [38], astroma [2–4]. Most of the data dealing with the role
of NO for the dermal compartment derive from a well regulatory phenomenon that might be directly impli-
cated in keratinocyte behavior during wound healing.established wound healing model that utilizes implanted
polyvinyl alcohol sponges that are implanted into subcu- Remarkably the mitogenic capacity of NO on keratino-
cytes appeared to result from its interference with intra-taneous pockets after dorsal incision of the skin [24].
NOS enzymatic activities could be clearly demonstrated cellular superoxide levels [41, 42]. Most important, the
mitogenic potency of NO for the keratinocyte as a targetusing this model system, as cells infiltrating the sponge
structures were responsible for the formation of nitrite cell could be proven in different models of wound repair,
as inhibition of NOS enzymatic activity resulted in de-and nitrate in the wound fluids [33]. Besides a large
number of wound macrophages [24], wound fibroblasts creased epithelial proliferation during repair of photo-
damaged skin [43], of skin excisions [9], and also of burnalso invade the implanted spongy structures [34]. Consis-
tently in all studies, the inhibition of wound NO synthesis wounds [44].
Obviously, there is evidence for a close correlationwas paralleled by a lowered wound breaking strength
and a markedly decreased collagen deposition [33–35]. between NO-mediated keratinocyte proliferation and
keratinocyte gene expression during skin repair in vivo.These data suggest that NO synthesis is critical to wound
collagen accumulation and acquisition of wound me- Exogenously added NO is capable of inducing the ex-
pression of important mediators of healing such as thechanical strength. Accordingly, sponge-isolated wound
fibroblasts express iNOS and produce NO in vitro, and angiogenic VEGF [45] and the PMN-attracting CXC-
chemokine IL-8 [46] in HaCaT keratinocytes. Basalinhibition of iNOS significantly decreased collagen syn-
thesis [34]. Moreover, transfection of these sponges with expression levels of the CC-chemokine macrophage che-
moattractant protein-1 (MCP-1) were simultaneously re-an iNOS cDNA resulted in a marked increase in collagen
deposition in vivo [36], and NO-donating agents en- duced [46]. Remarkably, when keratinocytes were ex-
posed to exogenously added or endogenously producedhanced fibroblast collagen synthesis in vitro [37]. These
studies again demonstrate that increased iNOS expres- NO in the presence of cytokines, the cells completely
change their expression patterns, as cytokine-inducedsion precedes an increase in fibroblast collagen synthesis.
In general, fibroblasts are highly resistant to NO- expression of VEGF and IL-8 was enhanced [45, 46],
whereas cytokine-triggered monocyte chemoattractantinduced necrosis and apoptosis [38]. Nevertheless, NO
is most likely to mediate an antiproliferative effect on protein-1 (MCP-1) and RANTES (regulated upon acti-
vation, normal T cell expressed and secreted) expressionskin fibroblasts. The increased mitogenic potency of hy-
pertrophic scar fibroblasts was clearly associated with levels were markedly reduced [46, 47]. It is reasonable
to hypothesize that wound keratinocytes might respondreduced eNOS expression [39], and fibroblast cytostasis
can be mediated in vitro using NO-donating agents to NO at the wound site in a similar manner, as kera-
tinoycte-derived VEGF, MCP-1 and also RANTES ex-[37, 38]. Interestingly, NO-mediated cytostasis and colla-
gen synthesis might be coupled, as NO-mediated cytosta- pression have been shown to be under the regulatory
control of iNOS-released NO during wound healing insis is associated with a net increase of collagen synthesis
by the cells [37]. vivo [45–47].
PERSPECTIVESNITRIC OXIDE AND
WOUND KERATINOCYTES Although a central role for protein-type growth factors
and mitogens during wound repair has been well knownSkin keratinocytes are capable of expressing all three
NOS isoforms [12–14, 16, 17]. Upon cutaneous injury, for years, the application of these factors in treatment
of wound healing disorders did not provide a break-proliferating keratinocytes of the wound margins have
been shown to strongly express iNOS [29]. Thus, it was through in clinical studies. One possible explanation for
the failure of protein-type mitogens to markedly acceler-reasonable to hypothesize that NO might be implicated
in the control of keratinocyte proliferation. About a de- ate closure of chronic wounds may be due tremendously
elevated protease activities in the wound fluids of chroniccade ago, a first line of evidence that argues for NO as
a regulator of keratinocyte mitogenicity came from a wounds [48]. This finding implicates that the molecular
environment of chronic wounds may impair the abilitystudy demonstrating that inhibition of keratinocyte pro-
liferation by inflammatory cytokines could be overcome of endogenous and exogenously applied growth factors
to stimulate healing. In this context, NO might representby NOS inhibitors or EGF, both of which blunt NO
production in the cells [40]. Moreover, in vitro studies a novel target molecule that circumvents the difficulties
that arise due to proteolytic cleavage of therapeuticallyusing NO-donating agents have convincingly shown that
keratinocytes respond to NO in a biphasic manner with applied growth factors in chronic wound situations. The
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pathophysiology, and pharmacology. Pharmacol Rev 43:109–142,small and short-lived radical molecule NO represents
1991
a potent mitogen for keratinocytes (comparable to the 12. Baudouin JE, Tachon P: Constitutive nitric oxide synthase is
present in normal human keratinocytes. J Invest Dermatol 106:428–mitogenic activities of EGF, or KGF) during wound heal-
431, 1996ing in vivo [9], a property that might be applied benefi-
13. Romero-Graillet C, Aberdam E, Biagoli N, et al: Ultraviolet B
cially to improve the re-epithelialization of chronic radiation acts through the nitric oxide and cGMP signal transduc-
tion pathway to stimulate melanogenesis in human melanocytes.wounds. Moreover, data from our laboratory implicate
J Biol Chem 271:28052–28056, 1996a capacity for NO that is most likely unique to this small
14. Shimizu Y, Sakai M, Umemura Y, et al: Immunohistochemical
molecule, and that makes it distinguishable from protein- localization of nitric oxide synthase in normal human skin: Expres-
sion of endothelial-type and inducible-type nitric oxide synthasetype growth factors: NO clearly modulates keratinocyte
in keratinocytes. J Dermatol 24:80–87, 1997responses to extracellular stimuli. Thus, mitogen-, or cy-
15. Wang R, Ghahary A, Shen YJ, et al: Human dermal fibroblasts
tokine-triggered gene expression in the cells can be dra- produce nitric oxide and express both constitutive and inducible
nitric oxide synthase isoforms. J Invest Dermatol 106:419–427, 1996matically altered by NO, indicating that a nitric oxide-
16. Bruch-Gerharz D, Fehsel K, Suschek C, et al: A proinflamma-mediated “pre-adjustment” of the keratinocyte is crucial
tory activity of interleukin 8 in human skin: expression of the
for its cellular response [45–47]. A closely controlled and inducible nitric oxide synthase in psoriatic lesions and cultured
keratinocytes. J Exp Med 184:2007–2012, 1996therefore homeostatic concentration of NO in the wound
17. Sirsjo A, Karlsson M, Gidlof A, et al: Increased expressionfluid during repair is most likely to adjust the wound
of inducible nitric oxide synthase in psoriatic skin and cytokine-
keratinocytes in the sense of “fine-tuning” the cells to stimulated cultured keratinocytes. Br J Dermatol 134:643–648, 1996
18. Qureshi AA, Hosoi J, Xu S, et al: Langerhans cells express induc-the available external stimuli. Accordingly, one would
ible nitric oxide synthase and produce nitric oxide. J Invest Derma-expect that disturbed wound healing conditions could
tol 107:815–821, 1996
be improved by application of exogenously added NO- 19. Kuhn A, Fehsel K, Lehmann P, et al: Aberrant timing in epidermal
expression of inducible nitric oxide synthase after UV irradiationdonating agents, as impaired repair is associated with a
in cutaneous lupus erythematosus. J Invest Dermatol 111:149–153,reduced availability of NO [49–51]. Promising results
1998
have been obtained from preliminary studies using non- 20. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V: Nitric oxide
and its implications in skin homeostasis and disease - A review.soluble, polymeric NONOates as NO-donating agents
Arch Dermatol Res 290:643–651, 1998during cutaneous healing in rats [52]. In addition to the
21. Stenger S, Donhauser N, Thuring H, et al: Reactivation of latent
well-investigated protein-type factors and mitogens, NO leishmaniasis by inhibition of inducible nitric oxide synthase. J
Exp Med 183:1501–1514, 1996may provide a novel therapeutical target to improve
22. Seifter E, Rettura G, Barbul A, et al: Arginine: An essentialseverely disturbed wound healing conditions.
amino acid for injured rats. Surgery 84:224–230, 1978
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